Conversations Around HIV PrEP With Adolescents Vary Between Urban, Rural Family Physicians
How Can Psoriasis, Depression Impact the Brain?
ICD Implantation Associated With Lower Risk of Mortality in Patients With CKD
What We’re Reading: COVID-19’s Contribution to 2022 Death Toll; Texas AG Requests Gender Change Data; HCV Treatment Lags in Prisons
Case Report Details Diagnostic Imaging for Rare Distal Cholangiocarcinoma Case
ICYMI: Highlights From the 2022 AHA Scientific Sessions
Modified Elimination Diet May Be Effective in Children With Eosinophilic Gastrointestinal Disorders
Case Report Details Rare Case of SLE With Cutaneous Leukocytoclastic Vasculitis
Impact of COVID-19 Seen in 2021 National Health Care Expenditures Report
Sleep Studies Needed to Confirm Subjective Improvement in OSA Symptoms After MAD Use
Dr Mary Cushman: Disparities in Pulmonary Embolism Exist; We Need to Ask Why
What We’re Reading: mRNA Vaccine Effective Against Melanoma; Proposed Addiction Treatment Policy; Maternal Health Disparities Before Abortion Bans
Tocilizumab Biosimilars Show Similar Safety, Tolerability, Immunogenicity to Reference: ACR Abstracts
Cannabis Improves Quality of Life in Women With Treatment-Resistant Fibromyalgia
Racial Disparities Shown for Delayed Diagnosis, Dermatologic Care in Hidradenitis Suppurativa
DOAC Prescriptions Gradually Displaced Warfarin in AF, CKD Treatment
TRANSFORM Data Support Liso-cel as Second-line Treatment for LBCL, Says Dr Jeremy Abramson
Dr Ajai Chari Talks Phase 1 Results of Bispecific Antibody Talquetamab for Multiple Myeloma
ICYMI: Top Content From AMCP Annual Meeting
Study Examines Success Factors in Finishing Cough Suppression Therapy
Study Examines Differences in Pulse Oximetry in Hospitalized Black, White Patients
In R/R CLL, Zanubrutinib Offers 35% Improved PFS Over Ibrutinib; Edge Greater for Higher-Risk Patients
Blinatumomab Significantly Improves OS in Newly Diagnosed B-ALL Patients Who Are MRD Negative After Initial Treatment
What We’re Reading: Cap on ACA Plans; CVS, Walgreens Settle Over Opioids; COVID-19 Diagnoses Rise After Thanksgiving
Reducing “Avoidable” ED Visits for Mental Health Could Cut Billions in Costs, Improve Patient Outcomes
Real-world Study Confirms Clinical Benefit of Ruxolitinib in Heavily Pretreated cGVHD
Telemedicine Care Quality, Social Vulnerability Index Barriers Measured for Patients With Epilepsy
Dr Elias Jabbour: Third-line Ponatinib “Optimal” for Patients With CML-CP Without T3151 Mutation
Study Identifies Sex-Related Differences in MDS Phenotypes, Genotypes, and Outcomes
Improved Patient-Reported Outcomes Shown With Mediterranean Diet in Parkinson Disease